Rocket Lab Crashed Back Toward Earth for 3 Months: This Analyst Says It’s About to Double
One Wall Street analyst has broken ranks with a target that would nearly double Rocket Lab's battered stock, but execution on a single make-or-break milestone stands between bulls and that payoff.
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Rocket Lab (NASDAQ:RKLB | RKLB Price Prediction) trades at $73.61 while the consensus Wall Street price target sits at $109.37, an implied upside of roughly 49%.
Rocket Lab is the second-most-recognized name in Western launch behind SpaceX, running the Electron small-lift rocket, building a growing Space Systems business, and preparing to debut the medium-lift Neutron. Its $2.36 billion backlog, pending acquisition of Iridium Communications, and expanding U.S. defense book have made it a favorite of space bulls.
One analyst now targets near-doubling upside while the median sees meaningful room to run. Yet the stock has slid from its highs, creating a disconnect worth examining.
Why the Rocket Rolled Over
The drawdown from Rocket Lab’s 52-week high of $151 has been severe, wiping out more than 51% of peak value before a recent bounce. Over the trailing three months alone, the stock is down 8.77%, sliding from $80.69 to the current level even as broader indexes advanced.
The catalyst is Neutron. Management said the window for an end-of-year launch is narrowing, with delivery to the pad targeted for Q4 2026 after a stage-1 tank test failure earlier this year. Bulls need Neutron to fly to justify the multiple.
Dilution has compounded concern. Rocket Lab pulled $1.08 billion through its ATM program in Q2, with Q3 guidance calling for roughly 641 million basic weighted shares. A Q2 non-GAAP free-cash-flow use of $110.1 million and price-to-sales ratio of 58 gave profit-takers reason to trim.
New Street Sees a Path Back to $150
The bull case is anchored by Pierre Ferragu of New Street Research, whose $150 Street-high 12-month target sits above a target range of $64 to $150 with a median hovering near $110. That $150 target implies roughly 104% upside from here, a near-doubling.
The thesis rests on Neutron commercialization at $50 to $55 million per flight, expanding government wins including a $397 million Flatellite award for the Space Force SB-AMTI program, and vertical integration through the Iridium deal, which serves more than 2.5 million subscribers and generated over $870 million in annual revenue last year.
Of 18 analysts covering the name, 3 rate it Strong Buy, 11 Buy, 4 Hold, and none Sell. Iridium shareholders approved the acquisition. The catalyst clock now runs on Neutron’s first flight and the mid-2027 Iridium close.
Analysts are watching execution: Q3 revenue guidance of $250 million to $265 million, more than $1 billion in new Q3 contracts already signed, and a backlog that grew 137% year-over-year. Miss on Neutron and the multiple compresses; hit and the model reprices.
How the Small-Cap Space Peers Stack Up
The pure-play space complex has not sold off uniformly. Rocket Lab and AST have declined while Redwire has advanced.
AST SpaceMobile (NASDAQ:ASTS) trades at $61.06 versus a consensus target of $79.61, implying 30% upside. Shares are down 15.93% year to date. Of 13 analysts covering, 4 rate it Buy or better, 7 Hold, and 2 Sell or worse, a more cautious posture than Rocket Lab.
Intuitive Machines (NASDAQ:LUNR) sits at $15.70 against a $29.50 target, an implied 88% upside. The stock is down 3.27% YTD with 7 Buy, 1 Hold, 1 Strong Sell, closest to RKLB in bullish tilt.
Redwire (NYSE:RDW) trades at $11.60 versus a $14.69 target, roughly 27% upside, with shares up 52.63% YTD. Coverage skews 6 Buy, 2 Hold, 1 Strong Sell.
Intuitive Machines shows the largest analyst-implied upside, but Rocket Lab is the only name where a mainstream shop publicly models a full double. Relative to peers, RKLB appears the higher-conviction bull case.
What the Data Actually Shows on RKLB
Rocket Lab trades at $73.61 with an average price target of $109.37 from 18 covering analysts, implying roughly 49% upside. The Street-high target from New Street Research at $150 would nearly double the stock.
Performance-wise, RKLB is up 5.52% year to date while the S&P 500 (via SPY) is up 12.52%, a notable underperformance versus the index. Rocket Lab is off 8.77% over three months but has rebounded 10.01% in the past month and 8.54% in the past week.
Analyst ratings breakdown:
- Strong Buy: 3
- Buy: 11
- Hold: 4
- Sell/Strong Sell: 0
Price targets are opinions, not guarantees, and Rocket Lab’s beta of 2.6 means the ride to either scenario will not be linear.
Weighing Rocket Lab at $73
The bull scenario requires Neutron reaching the pad on the Q4 2026 timeline, the Iridium acquisition closing in mid-2027 as planned, and the Space Systems backlog converting at current cadence. That path supports the consensus $109 and keeps New Street’s $150 in play. The bear scenario materializes if Neutron slips into 2027, dilution erodes per-share value, or Iridium integration proves messier than expected.
Cautiously constructive. The bull case is differentiated because no other Western pure-play combines launch, spacecraft, and a global comms constellation. The bear case is straightforward execution risk on a company still losing money. At roughly half the Street-high target and 49% below consensus, the risk/reward tilts positive for investors who can stomach the beta.
Contact [email protected] for any questions or corrections.
Alex Sirois is a financial writer with experience spanning both retail and institutional investing. He has written for InvestorPlace and held roles at BNY Mellon and Bernstein, giving him a perspective that bridges Main Street portfolios and Wall Street analysis.
Alex holds an MBA from George Washington University and has built his career across multiple industries, including e-commerce, education, and translation — a breadth of experience that informs how he breaks down complex financial topics for everyday investors. His writing is conversational, actionable, and grounded in long-term, buy-and-hold investing principles.
At 247 Wall St., Alex focuses on delivering analysis that is both accessible and useful, with a clear emphasis on helping readers make more informed decisions with their money.
